News

As per the agreement, Panacea Biotec will involve in product development and manufacturing, while Osmotica will lead product registration, legal matters as well as commercialization. The collaboration products

According to the agreement, Pulmatrix will receive $1.4m in upfront and milestone-driven funding for the effort from the CFFT, along with introductions to cystic fibrosis academic researchers and

The randomised, double-blind, placebo-controlled study will evaluate the efficacy and safety of GBR 500 in patients with moderate to severe UC. Glenmark Pharmaceuticals chief scientific officer Dr. Michael

The company anticipates initiation of product shipment shortly. Lannett president and chief executive officer Arthur Bedrosian said that sales of Butalbital, Acetaminophen and Caffeine tablets have been climbing

The pending US litigation is concerned with the production and sale of generic formulations of Concerta (methylphenidate hydrochloride extended release tablets, 18mg, 27mg, 36mg, and 54mg). Pursuant to

The agreement has been made keeping in view the healthcare providers, according to Fusion. Through the agreement, Fusion will offer Unisys solutions, such as Stealth Solution Suite of

The report was published in an article entitled "Feeder-Free Derivation of Human Induced Pluripotent Stem Cells with Messenger RNA". Allele scientists presented the fastest and safest method to

Vertellus is focused on the manufacturing ingredients used in pharmaceuticals, personal care, nutrition and agriculture. The product lines HORN Essentials will represent for Vertellus include Crystal brand castor

One Lambda, which had 2011 revenue of $182m, will become part of Thermo Fisher’s Specialty Diagnostics Segment. Thermo Fisher Scientific president and chief executive officer Marc Casper said